Nondihyropyridine calcium channel blockers (diltiazem and verapamil) are contraindicated in patients with HF (except in HFNEF) because of their negative inotropic effects. Although dihydropyridine ...

However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF, where differences in reverse ...

MONDAY, Feb. 3, 2025 (HealthDay News) -- A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the beta blocker propranolol to ward ...

MONDAY, Feb. 3, 2025 (HealthDay News) -- A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the beta blocker propranolol to ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The Bank's Monetary Policy Committee (MPC) voted for a quarter-point reduction after similar cuts in August and November last ...